Patents Assigned to GNOSIS S.p.A.
  • Patent number: 8771992
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Grant
    Filed: November 13, 2013
    Date of Patent: July 8, 2014
    Assignee: GNOSIS S.p.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Publication number: 20140073772
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Application
    Filed: November 13, 2013
    Publication date: March 13, 2014
    Applicant: GNOSIS S.P.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Patent number: 8664196
    Abstract: The present invention provides a shark-like chondroitin sulphate and a process for the preparation thereof. In particular, the present invention relates to a shark-like chondroitin sulphate, having a very low amount of 4-sulphate, a high charge density and a biological activity comparable to natural chondroitin sulphates. The invention also relates to a process for the preparation of said shark-like chondroitin sulphate affording substantially higher productivities and better reproducibility of product quality. The shark-like chondroitin sulphate of the invention shows a high molecular mass and its in vitro biological and anti-inflammatory effectiveness has been shown to be comparable to that of natural products making this polysaccharide potentially useful as a drug in pharmaceutical preparations and nutraceuticals.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: March 4, 2014
    Assignee: Gnosis S.p.A.
    Inventors: Ermanno Valoti, Niccolò Miraglia, Davide Bianchi, Marco Valetti, Paola Bazza
  • Patent number: 8609394
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: December 17, 2013
    Assignee: Gnosis S.p.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Publication number: 20120295865
    Abstract: The present invention provides a shark-like chondroitin sulphate and a process for the preparation thereof. In particular, the present invention relates to a shark-like chondroitin sulphate, having a very low amount of 4-sulphate, a high charge density and a biological activity comparable to natural chondroitin sulphates. The invention also relates to a process for the preparation of said shark-like chondroitin sulphate affording substantially higher productivities and better reproducibility of product quality. The shark-like chondroitin sulphate of the invention shows a high molecular mass and its in vitro biological and anti-inflammatory effectiveness has been shown to be comparable to that of natural products making this polysaccharide potentially useful as a drug in pharmaceutical preparations and nutraceuticals.
    Type: Application
    Filed: May 20, 2011
    Publication date: November 22, 2012
    Applicant: GNOSIS S.P.A.
    Inventors: Ermanno Valoti, Niccoló Miraglia, Davide Bianchi, Marco Valetti, Paola Bazza
  • Publication number: 20120010399
    Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
    Type: Application
    Filed: June 24, 2011
    Publication date: January 12, 2012
    Applicant: GNOSIS S.P.A.
    Inventors: Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
  • Patent number: 7947662
    Abstract: The present invention relates to folates, compositions and uses thereof; In particular, this invention describes a crystalline or amorphous compound which is a substituted or unsubstituted folate or a reduced folate, or the natural or unnatural isomers thereof, of at least one organic base, as well as compositions and uses thereof. The compounds of the invention show a long lasting stability as well as a peculiarly high water-solubility.
    Type: Grant
    Filed: February 20, 2008
    Date of Patent: May 24, 2011
    Assignee: GNOSIS S.p.A.
    Inventors: Ermanno Valoti, Davide Bianchi, Marco Valetti
  • Publication number: 20110020301
    Abstract: The use of S-adcnosylmcthioninc (SAM) in combination with supcmxidc dismutase (SOD) for the preparation of medicaments for the treatment of Alzheimer's disease.
    Type: Application
    Filed: February 25, 2009
    Publication date: January 27, 2011
    Applicant: GNOSIS S.P.A.
    Inventors: Sigfrido Scarpa, Andrea Fuso, Rosellina Damiani, Mauro Rossini
  • Patent number: 7718407
    Abstract: A process for the preparation of vitamin K2 (MK-7) comprising the culture of Bacillus subtilis mutant strain GN13/72-DSM 17766 deposited on Dec. 5, 2005 at the DSMZ.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: May 18, 2010
    Assignee: GNOSIS S.p.A.
    Inventors: Alberto Benedetti, Simona Daly, Roberto Xaiz, Hermes Pagani
  • Publication number: 20090209543
    Abstract: The present invention relates to folates, compositions and uses thereof; In particular, this invention describes a crystalline or amorphous compound which is a substituted or unsubstituted folate or a reduced folate, or the natural or unnatural isomers thereof, of at least one organic base, as well as compositions and uses thereof. The compounds of the invention show a long lasting stability as well as a peculiarly high water-solubility.
    Type: Application
    Filed: February 20, 2008
    Publication date: August 20, 2009
    Applicant: GNOSIS S.p.A.
    Inventors: Ermanno Valoti, Davide Bianchi, Marco Valetti